Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Neurodegeneration biomarkers and longitudinal studies

Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline.

Neel H Mehta; Liangdong Zhou; Yi Li; Laura Beth McIntire; Anna Nordvig; Tracy Butler; Mony de Leon; Gloria C Chiang

Originally published in Scientific reports · 2023-05-31

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Neuroinflammation is believed to be a key process in Alzheimer's disease (AD) pathogenesis. Recently, the neutrophil-to-lymphocyte (NLR) and lymphocyte-to-monocyte ratios (LMR) have been proposed to be useful peripheral markers of inflammation. However, it is unclear how these inflammatory ratios relate to AD pathology, such as β-amyloid (Aβ) plaques and tau tangles. Using 18 F-florbetapir and 18 F-flortaucipir positron emission tomography (PET), we sought to determine how the NLR and LMR are associated with AD pathology both cross-sectionally and longitudinally. We further evaluated associations between the NLR and LMR and longitudinal cognitive decline. Using data from the Alzheimer's Disease Neuroimaging Initiative, we analyzed blood, PET, and cognitive data from 1544 subjects-405 cognitively normal, 838 with mild cognitive impairment (MCI), and 301 with AD. Associations between the NLR and LMR and Aβ and tau on PET were assessed using ordinary least-squares and mixed-effects regression models, while adjusting for age, sex, years of education, and apolipoprotein E ε2 or ε4 carrier status.

Results

Baseline characteristics and group comparisons for the overall cohort are shown in Table 1. Compared to the NC group, the MCI group was younger (mean ± SD: MCI 73 ± 7.6 vs. NC 75 ± 5.7 years, p < 0.001) and had a higher proportion of males (MCI 59% male vs NC 50% male, p = 0.004). The MCI and AD groups had fewer years of education (MCI 15.9 ± 2.9 vs. NC 16.3 ± 2.7 years, p = 0.03; AD 15.1 ± 3.0 vs NC, p = 0.003), fewer APOE ε2 carriers (MCI 6% vs. NC 14%, p < 0.001; AD 4% vs. NC, p < 0.001), and more APOE ε4 carriers (MCI 49% vs. NC 27%, p < 0.001; AD 68% vs. NC, p < 0.001) than the NC group.

Discussion

The major findings of our study were: (1) MCI and AD were both associated with a higher NLR and lower LMR, (2) the NLR, but not the LMR, was significantly associated with higher baseline Aβ on PET and longitudinal change in ADAS, and (3) neither NLR or LMR was associated with tau deposition on PET cross-sectionally or longitudinally. Taken together, our analysis suggests that alterations in the balance of peripheral neutrophils and lymphocytes, as described by the NLR, possibly reflecting altered innate versus adaptive immunity, are related to Aβ deposition and longitudinal cognitive change.

Conclusions

As the field moves toward blood-based markers of AD, systemic markers of inflammation are highly promising biomarkers and potential therapeutic targets for disease modification. Our study provides strong evidence for a higher NLR and lower LMR in MCI and AD, partially mediated by Aβ pathology. Future community-based, prospective studies may assess the direct role of microglial activation and cytokine levels in linking peripheral inflammation, central inflammation, and AD.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?